161 related articles for article (PubMed ID: 22210807)
1. In vitro assessment of blood compatibility: residual and dynamic markers of cellular activation.
Johnson G; Curry B; Cahalan L; Prater R; Beeler M; Gartner M; Biggerstaff J; Cahalan P
J Biomater Appl; 2013 May; 27(8):925-36. PubMed ID: 22210807
[TBL] [Abstract][Full Text] [Related]
2. Material-specific thrombin generation following contact between metal surfaces and whole blood.
Hong J; Azens A; Ekdahl KN; Granqvist CG; Nilsson B
Biomaterials; 2005 Apr; 26(12):1397-403. PubMed ID: 15482827
[TBL] [Abstract][Full Text] [Related]
3. Fibrinogen adsorption, platelet adhesion and thrombin generation at heparinized surfaces exposed to flowing blood.
Keuren JF; Wielders SJ; Willems GM; Morra M; Lindhout T
Thromb Haemost; 2002 Apr; 87(4):742-7. PubMed ID: 12008960
[TBL] [Abstract][Full Text] [Related]
4. The role of whole blood in thrombin generation in contact with various titanium surfaces.
Thor A; Rasmusson L; Wennerberg A; Thomsen P; Hirsch JM; Nilsson B; Hong J
Biomaterials; 2007 Feb; 28(6):966-74. PubMed ID: 17095084
[TBL] [Abstract][Full Text] [Related]
5. Effect of complement inhibition and heparin coating on artificial surface-induced leukocyte and platelet activation.
Lappegård KT; Fung M; Bergseth G; Riesenfeld J; Lambris JD; Videm V; Mollnes TE
Ann Thorac Surg; 2004 Mar; 77(3):932-41. PubMed ID: 14992902
[TBL] [Abstract][Full Text] [Related]
6. Surface engineering of polycaprolactone by biomacromolecules and their blood compatibility.
Khandwekar AP; Patil DP; Shouche Y; Doble M
J Biomater Appl; 2011 Aug; 26(2):227-52. PubMed ID: 20511382
[TBL] [Abstract][Full Text] [Related]
7. Effects of surface-bound and intravenously administered heparin on cell-surface interactions: inflammation and coagulation.
Johnson G; Curry B; Cahalan L; Prater R; Biggerstaff J; Hussain A; Gartner M; Cahalan P
Perfusion; 2013 May; 28(3):263-71. PubMed ID: 23401339
[TBL] [Abstract][Full Text] [Related]
8. Hirudin versus heparin for use in whole blood in vitro biocompatibility models.
Bexborn F; Engberg AE; Sandholm K; Mollnes TE; Hong J; Nilsson Ekdahl K
J Biomed Mater Res A; 2009 Jun; 89(4):951-9. PubMed ID: 18470919
[TBL] [Abstract][Full Text] [Related]
9. Blood coagulation on biomaterials requires the combination of distinct activation processes.
Sperling C; Fischer M; Maitz MF; Werner C
Biomaterials; 2009 Sep; 30(27):4447-56. PubMed ID: 19535136
[TBL] [Abstract][Full Text] [Related]
10. Improved in vitro blood compatibility of polycaprolactone nanowire surfaces.
Leszczak V; Popat KC
ACS Appl Mater Interfaces; 2014 Sep; 6(18):15913-24. PubMed ID: 25184556
[TBL] [Abstract][Full Text] [Related]
11. Platelet compatibility of an artificial surface modified with functionally active heparin.
Mollnes TE; Videm V; Christiansen D; Bergseth G; Riesenfeld J; Hovig T
Thromb Haemost; 1999 Sep; 82(3):1132-6. PubMed ID: 10494777
[TBL] [Abstract][Full Text] [Related]
12. The ability of surface characteristics of materials to trigger leukocyte tissue factor expression.
Fischer M; Sperling C; Tengvall P; Werner C
Biomaterials; 2010 Mar; 31(9):2498-507. PubMed ID: 20035991
[TBL] [Abstract][Full Text] [Related]
13. Luminal surface microgeometry affects platelet adhesion in small-diameter synthetic grafts.
Losi P; Lombardi S; Briganti E; Soldani G
Biomaterials; 2004 Aug; 25(18):4447-55. PubMed ID: 15046935
[TBL] [Abstract][Full Text] [Related]
14. Artificial surface-induced cytokine synthesis: effect of heparin coating and complement inhibition.
Lappegård KT; Fung M; Bergseth G; Riesenfeld J; Mollnes TE
Ann Thorac Surg; 2004 Jul; 78(1):38-44; discussion 44-5. PubMed ID: 15223398
[TBL] [Abstract][Full Text] [Related]
15. Thrombin, kallikrein and complement C5b-9 adsorption on hydrophilic and hydrophobic titanium and glass after short time exposure to whole blood.
Yahyapour N; Eriksson C; Malmberg P; Nygren H
Biomaterials; 2004 Jul; 25(16):3171-6. PubMed ID: 14980412
[TBL] [Abstract][Full Text] [Related]
16. A new in vitro model to study interaction between whole blood and biomaterials. Studies of platelet and coagulation activation and the effect of aspirin.
Hong J; Nilsson Ekdahl K; Reynolds H; Larsson R; Nilsson B
Biomaterials; 1999 Apr; 20(7):603-11. PubMed ID: 10208402
[TBL] [Abstract][Full Text] [Related]
17. Blood compatibility of SPUU-PEO-heparin graft copolymers.
Park KD; Kim WG; Jacobs H; Okano T; Kim SW
J Biomed Mater Res; 1992 Jun; 26(6):739-56. PubMed ID: 1527098
[TBL] [Abstract][Full Text] [Related]
18. Measurement of the rate of thrombin production in human plasma in contact with different materials.
Rollason G; Sefton MV
J Biomed Mater Res; 1992 May; 26(5):675-93. PubMed ID: 1512285
[TBL] [Abstract][Full Text] [Related]
19. Covalently immobilized thrombomodulin inhibits coagulation and complement activation of artificial surfaces in vitro.
Sperling C; Salchert K; Streller U; Werner C
Biomaterials; 2004 Sep; 25(21):5101-13. PubMed ID: 15109834
[TBL] [Abstract][Full Text] [Related]
20. Biofunctionalization of titanium surface with multilayer films modified by heparin-VEGF-fibronectin complex to improve endothelial cell proliferation and blood compatibility.
Wang HG; Yin TY; Ge SP; Zhang Q; Dong QL; Lei DX; Sun DM; Wang GX
J Biomed Mater Res A; 2013 Feb; 101(2):413-20. PubMed ID: 22865832
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
